Clinical Trial Update: Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing T4020 to vehicle in chronic neurotrophic keratitis or corneal ulcer completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ulcer
• Neurotrophic Keratitis

Drugs mentioned

• T4020

Snippet

Sponsor: Laboratoires Thea | Conditions: Keratitis, Corneal Ulcer | Phase 3 | Status: COMPLETED | Results posted: 2019-10-07